The Manufacturers Life Insurance Company trimmed its position in Chimera Investment Co. (NYSE:CIM – Free Report) by 6.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,487 shares of the real estate investment trust’s stock after selling 2,500 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Chimera Investment were worth $539,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently bought and sold shares of the stock. Sterling Capital Management LLC raised its stake in Chimera Investment by 4.9% during the 4th quarter. Sterling Capital Management LLC now owns 29,111 shares of the real estate investment trust’s stock valued at $408,000 after purchasing an additional 1,357 shares during the last quarter. MetLife Investment Management LLC raised its stake in Chimera Investment by 5.8% during the 4th quarter. MetLife Investment Management LLC now owns 49,231 shares of the real estate investment trust’s stock valued at $689,000 after purchasing an additional 2,694 shares during the last quarter. Atria Investments Inc raised its stake in Chimera Investment by 18.1% during the 4th quarter. Atria Investments Inc now owns 19,672 shares of the real estate investment trust’s stock valued at $275,000 after purchasing an additional 3,018 shares during the last quarter. Quarry LP increased its holdings in Chimera Investment by 1,691.7% in the 4th quarter. Quarry LP now owns 3,243 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 3,062 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S increased its holdings in Chimera Investment by 4.0% in the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 82,680 shares of the real estate investment trust’s stock valued at $1,158,000 after buying an additional 3,160 shares during the period. 48.44% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Chimera Investment
In related news, Director Gerard Creagh acquired 12,500 shares of the firm’s stock in a transaction on Tuesday, March 11th. The shares were purchased at an average price of $13.31 per share, with a total value of $166,375.00. Following the acquisition, the director now directly owns 138,127 shares in the company, valued at $1,838,470.37. The trade was a 9.95% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 0.91% of the stock is owned by insiders.
Chimera Investment Stock Up 0.3%
Chimera Investment (NYSE:CIM – Get Free Report) last posted its earnings results on Thursday, May 8th. The real estate investment trust reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.03. Chimera Investment had a net margin of 20.28% and a return on equity of 7.00%. The business had revenue of $69.22 million for the quarter, compared to analyst estimates of $72.07 million. Equities research analysts anticipate that Chimera Investment Co. will post 1.57 EPS for the current fiscal year.
Chimera Investment Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st were issued a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 10.54%. The ex-dividend date of this dividend was Monday, March 31st. Chimera Investment’s payout ratio is 98.67%.
Wall Street Analyst Weigh In
Several brokerages have issued reports on CIM. StockNews.com raised shares of Chimera Investment from a “hold” rating to a “buy” rating in a report on Thursday. Royal Bank of Canada raised shares of Chimera Investment to a “moderate buy” rating in a report on Friday, March 14th. UBS Group raised shares of Chimera Investment from a “neutral” rating to a “buy” rating and boosted their price target for the company from $11.50 to $15.00 in a report on Wednesday. Finally, JMP Securities reissued a “market perform” rating on shares of Chimera Investment in a report on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, Chimera Investment currently has a consensus rating of “Moderate Buy” and a consensus price target of $15.50.
View Our Latest Analysis on CIM
Chimera Investment Company Profile
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
Read More
- Five stocks we like better than Chimera Investment
- How to Profit From Value Investing
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- How to Use Stock Screeners to Find Stocks
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- What is a Death Cross in Stocks?
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Want to see what other hedge funds are holding CIM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chimera Investment Co. (NYSE:CIM – Free Report).
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.